)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
JMDC
JMDC (4483) investor relations material
JMDC Q2 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2027 earnings summary5 Nov, 2026
Executive summary
FY2027 H1 revenue rose 19.5% YoY to ¥27,571m and EBITDA increased 14.6% to ¥6,333m; both exceeded the H1 forecast disclosed after Q1.
Q2 revenue growth was 21% YoY excluding revenue brought forward into Q1, versus 18% in Q1; management described momentum as accelerating.
Growth was led by Healthcare–Big Data, with revenue up 21.4%; Tele-medicine revenue rose 7.3%.
Financial highlights
Revenue was ¥27,571m, gross profit ¥14,656m, operating profit ¥4,604m and profit before tax ¥4,340m.
Profit attributable to owners of the parent rose 24.2% YoY to ¥2,951m; basic EPS was ¥45.10.
Comprehensive income was ¥2,767m versus ¥2,419m YoY; OCI included a ¥197m loss on financial assets measured at fair value through OCI.
Total assets were ¥158,611m and total equity was ¥84,957m as of September 30, 2026.
H1 exceeded the Q1-disclosed forecasts for revenue, operating profit and EBITDA.
Outlook and guidance
FY2027 guidance is unchanged: revenue ¥60,500m, operating profit ¥11,500m, profit before tax ¥11,000m and EBITDA ¥15,000m.
Forecast profit attributable to owners is ¥7,100m, basic EPS ¥108.19 and annual dividend ¥18 per share; the announced dividend forecast is unchanged.
H1 represented 46% of revenue guidance and 42% of EBITDA guidance; the plan is weighted toward H2.
H2 EBITDA growth of ~13% is required to meet the annual plan, below H1's 14.6%; inquiries are building, primarily in Industry.
H2 profit growth is expected to moderate as investment continues in AI talent and data infrastructure and the sales structure is strengthened.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from JMDC
- Double-digit revenue and EBITDA growth driven by strong Industry and segment demand.4483
Q1 2027 - FY2025 revenue and EBITDA rose 21%, with FY2026 targeting 20% revenue growth and AI investment.4483Q4 2026
- Strong revenue and profit growth, with rising margins in healthcare data and tele-medicine.4483Q3 2026
- Strong revenue and profit growth, led by Healthcare - Big Data and Tele-medicine segments.4483Q2 2026
- Revenue and profit surged, driven by Healthcare - Big Data and strong business visibility.4483Q1 2026
- Revenue up 26% YoY, profit down on one-offs, but outlook remains strong.4483Q1 2025
- Revenue and EBITDA soared, but net profit fell as costs rose.4483Q2 2025
- Core healthcare data and tele-medicine segments drove record growth and future expansion.4483Q4 2025
- Healthcare - Big Data drove 37% revenue growth, with robust outlook and continued investments.4483Q3 2025
Next JMDC earnings date
Q3 20273 Feb, 2027
JMDC
Next JMDC earnings date
Q3 20273 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
JMDC Inc., listed under the ticker 4483 on the Tokyo Stock Exchange, is a Japanese company primarily engaged in the health big data business. The company's operations are diversified across three main segments: Health Big Data, Telemedicine, and Dispensing Pharmacy Support. In the Health Big Data segment, JMDC Inc. focuses on services such as receipt data analysis, health promotion solutions, and personal health information platforms. It also builds, manages, and analyzes medical databases, including receipt and medical examination data, and develops and provides systems using drug databases for medical institutions. The Telemedicine segment offers remote image diagnosis matching services and infrastructure systems for remote image diagnosis. The Dispensing Pharmacy Support segment, on the other hand, develops and provides business systems and electronic medication records for dispensing pharmacies, in addition to operating dispensing pharmacies. MDC Inc. is headquartered in Minato, Tokyo, Japan, and its shares are listed on the Tokyo Stock Exchange.